Epclusa

Made by

• Gilead Sciences

Active Ingredient

Sofosbuvir and velpatasvir

Prospectus

Approval date

2019/1/8

Treats

• Hepatitis C, Hepatitis C virus (HCV) infection

Dosages

• EPCLUSA Combination Tablets - 61157.8円／錠